| P50 | author | Avner Friedman | Q4231796 |
| P2093 | author name string | Luke Russell | |
| | Balveen Kaur | |
| | Karly Jacobsen | |
| P2860 | cites work | The human growth factor-inducible immediate early gene, CYR61, maps to chromosome 1p | Q24318489 |
| | Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 |
| | Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM | Q33712977 |
| | Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses | Q33773376 |
| | miR451 and AMPK mutual antagonism in glioma cell migration and proliferation: a mathematical model | Q34113536 |
| | Role of microglia in glioma biology | Q34309564 |
| | Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer | Q34327051 |
| | CCN1 and CCN2: blood brothers in angiogenic action. | Q34352095 |
| | Seeing the Portal in Herpes Simplex Virus Type 1 B Capsids | Q34529819 |
| | Flow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigation. | Q34721575 |
| | Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses | Q35036505 |
| | The LDL-HDL profile determines the risk of atherosclerosis: a mathematical model | Q35118830 |
| | Chondroitinase ABC I-mediated enhancement of oncolytic virus spread and antitumor efficacy | Q35119552 |
| | Choindroitinase ABC I-mediated enhancement of oncolytic virus spread and anti tumor efficacy: a mathematical model | Q35210355 |
| | Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas | Q35216380 |
| | A mechanistic proof-of-concept clinical trial with JX-594, a targeted multi-mechanistic oncolytic poxvirus, in patients with metastatic melanoma | Q35285695 |
| | Role of cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance | Q35618563 |
| | Antitumor efficacy of 34.5ENVE: a transcriptionally retargeted and "Vstat120"-expressing oncolytic virus | Q35750059 |
| | Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma | Q36004674 |
| | A model on the influence of age on immunity to infection with Mycobacterium tuberculosis | Q36580321 |
| | BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. | Q37028013 |
| | Oncolytic HSV-1 infection of tumors induces angiogenesis and upregulates CYR61 | Q37138130 |
| | A methodology for performing global uncertainty and sensitivity analysis in systems biology. | Q37197756 |
| | Advances in oncolytic virus therapy for glioma | Q37287118 |
| | Oncolytic virus therapy for cancer: the first wave of translational clinical trials. | Q38073520 |
| | Invasion as target for therapy of glioblastoma multiforme | Q38124653 |
| | Matricellular protein CCN1/CYR61: a new player in inflammation and leukocyte trafficking | Q38196726 |
| | Targeting adaptive glioblastoma: an overview of proliferation and invasion | Q38235930 |
| | Suppression of autophagy enhanced growth inhibition and apoptosis of interferon-β in human glioma cells. | Q39208754 |
| | Targeting localized immune suppression within the tumor through repeat cycles of immune cell-oncolytic virus combination therapy. | Q39683647 |
| | Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme | Q40495113 |
| | Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors | Q41454479 |
| | A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer | Q45371067 |
| | Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro | Q48089474 |
| | Serum IL-8 and MCP-1 concentration do not identify patients with enlarging contusions after traumatic brain injury | Q48425211 |
| | Glioma virotherapy: effects of innate immune suppression and increased viral replication capacity | Q48643464 |
| | Distribution and characterization of microglia/macrophages in human brain tumors | Q48932065 |
| | Interaction of tumor with its micro-environment: A mathematical model. | Q51775767 |
| | Tumor Restrictions to Oncolytic Virus. | Q51846287 |
| P433 | issue | 6 | |
| P921 | main subject | macrophage | Q184204 |
| | mathematical model | Q486902 |
| P6104 | maintained by WikiProject | WikiProject Mathematics | Q8487137 |
| P1104 | number of pages | 29 | |
| P304 | page(s) | 984-1012 | |
| P577 | publication date | 2015-03-11 | |
| P1433 | published in | Bulletin of Mathematical Biology | Q2720088 |
| P1476 | title | Effects of CCN1 and Macrophage Content on Glioma Virotherapy: A Mathematical Model | |
| P478 | volume | 77 | |